Medical News

RSS

Santen files IND for Clinical Data's ATL313 for primary open angle glaucoma and ocular hypertension

Clinical Data, Inc., today announced that Santen Pharmaceutical Co., Ltd., has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for Clinical Data's highly selective adenosine A2A agonist, ATL313, for the indication of primary open angle glaucoma and ocular hypertension.

From Santen Pharmaceutical Co., Ltd. 23 Dec 2010

Arsenic agent for leukemia beneficial in treating medulloblastoma, Ewing's Sarcoma

Researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, have found that an arsenic-based agent already FDA-approved for a type of leukemia may be helpful in another hard-to-treat cancer, Ewing's Sarcoma (ES). The research, based on animal studies, also suggests the drug might be beneficial in treating medulloblastoma, a highly malignant pediatric brain cancer.

23 Dec 2010

Procognia grants Euro-Diagnostica license to provide diagnostic services for gastric cancer

Procognia is proud to announce that yesterday it signed a binding memorandum of understanding with Euro-Diagnostica (ED), a European diagnostic company that currently operates in the Scandinavian and Benelux markets, and is expected to expand its activity into other markets which may include Germany, Austria, Switzerland, and the UK in the near future.

23 Dec 2010

Promising initial data from STABLE clinical trial for endovascular treatment of Type B aortic dissection

Study investigators reported positive steps in Cook Medical's efforts to gain FDA approval of the treatment assessed in the STABLE clinical trial, designed to evaluate the safety and efficacy of a proximal endograft and a distal uncovered stent for the endovascular treatment of Type B aortic dissection for purposes of seeking FDA approval. The findings were presented by Dr. Joseph Lombardi at the 37th annual VEITHsymposium.

23 Dec 2010

Pelosi supports James Zadroga 9/11 Health and Compensation Act on the House floor

Speaker Nancy Pelosi spoke on the House floor this afternoon in support of the James Zadroga 9/11 Health and Compensation Act, which passed the House by a vote of 206 to 160. Below are the Speaker's remarks.

23 Dec 2010

St. Luke’s second in nation to perform EVAR with Endurant AAA Stent Graft System

An 80-year-old patient at St. Luke's Episcopal Hospital (St. Luke's) in Houston became the second in the nation to be treated with a newly approved FDA device for an abdominal aortic aneurysm (AAA). The condition, often called, "the silent killer," is a dangerous bulge or ballooning in the main artery of the body that typically causes no symptoms until it ruptures.

23 Dec 2010

Scientist discovers molecular switch controlling synthesis of ribosomes

A scientist from the Florida campus of The Scripps Research Institute has discovered a molecular switch that controls the synthesis of ribosomes. Ribosomes are the large machineries inside all living cells that produce proteins, the basic working units of any cell. These new findings offer a novel target for potential treatments for a range of diseases, including cancer.

23 Dec 2010

Key to long-term weight-loss success is finding unique individual level of carbohydrate tolerance

Recent media coverage suggests that the reported wedding diet of Carole Middleton, mother of future British princess Kate Middleton, is something brand new. Yet the Dukan Diet is just another variation of the Atkins Diet™, but with some nutritional recommendations that simply don't make sense or are guaranteed to fail.

23 Dec 2010

Later onset of puberty associated with malnutrition, earlier onset to childhood obesity

The timing of the onset of puberty is linked to levels of nutrition: later onset is associated with malnutrition, while earlier onset is linked to childhood obesity. A team of researchers, led by Carol Elias, at the University of Texas Southwestern Medical Center, Dallas, has now generated data in mice that run counter to current thinking about the molecular pathway by which nutrition status affects the onset of puberty. Further, the team defines a new regulatory pathway for the process, which, if confirmed in humans, could potentially lead to new approaches to treating disorders of puberty and fertility.

23 Dec 2010

Discovery highlights potential to combat HIV/AIDS

Researchers at the University of Minnesota have discovered how HIV binds to and destroys a specific human antiviral protein called APOBEC3F. The results suggest that a simple chemical change can convert APOBEC3F to a more effective antiviral agent and that shielding of a common feature shared by related proteins may yield a similar outcome.

23 Dec 2010

Congress approves stopgap spending measure; Some funding for federal agencies, global health programs delayed

Congress Tuesday "approved a temporary spending bill [.pdf] that will fund the federal government for another 10 weeks through March 4 in order to avoid a government shutdown," Agence France-Presse reports.

23 Dec 2010

BioTime enters MTA with UC to make research-grade hES cell lines

BioTime, Inc. today announced a material transfer agreement (MTA) with the University of California (UC) system to make five research-grade human embryonic stem (hES) cell lines available to UC system researchers. These lines are genetically identical to a bank of GMP-compliant hES cell lines that will be made available to California-based researchers under a recent agreement between BioTime and the California Institute for Regenerative Medicine (CIRM).

23 Dec 2010

EPA to clean up vector-breeding site to eliminate dengue epidemic

To control the severe dengue epidemic, the Environmental Protection Administration (EPA) said the first priority is to locate diagnosed patients and eliminate virus-carrying mosquitoes, the vectors of Dengue fever, and called on all people to clean up mosquito breeding sites.

23 Dec 2010

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Novavax, and scientists at the University of Massachusetts Medical School, led by Dr. Trudy Morrison, published in the January 2011 issue of The Journal of Virology, a report indicating that a novel virus-like particle vaccine candidate against respiratory syncytial virus (RSV) protects mice from a live virus challenge.

23 Dec 2010

AADR testifies at FDA Advisory Panel meeting on dental amalgam

On December 14-15, 2010, the U.S. Food and Drug Administration (FDA) convened an Advisory Panel to discuss several scientific issues that may affect the regulation of dental amalgam. At the conclusion of the hearing, the Panel voted to recommend that the FDA conduct further review of the material's safety.

23 Dec 2010

BSD in final process of establishing international distribution networks for new microwave ablation product line

Maximizing production capacity, completing placement of systems in multiple hospitals, and witnessing early clinical successes with the MicroThermX Microwave Ablation line of products have paved the way for BSD Medical Corporation to take its sales and distribution strategy to the next level. BSD is in the final process of establishing both domestic and international distribution networks dedicated to selling its exciting new microwave ablation product line.

23 Dec 2010

Liberty Dialysis and Renal Advantage to form the third largest dialysis provider in the U.S.

Liberty Dialysis and Renal Advantage today announced that the deal to form the 3rd largest dialysis provider in the U.S. has closed. The transaction was completed on December 17, 2010. The new company has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

23 Dec 2010

Myrexis commences Azixa controlled two-arm Phase 2b clinical study in GBM

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it has initiated a controlled two-arm Phase 2b clinical study of Azixa (verubulin) as a front-line treatment for glioblastoma multiforme (GBM).

23 Dec 2010

Researchers identify new regulator that play a critical role in B cell development

A team at the Institut de recherches cliniques de Montr-al led by Dr. Tarik M-r-y, President and Scientific Director of the institute and Director of the Hematopoiesis and Cancer research unit, will be publishing an important breakthrough in tomorrow's issue of Immunity, a scientific journal from the Cell Press group. The researchers identified a new regulator playing a critical role in the development B cells, which produce antibodies.

23 Dec 2010

Northstar Healthcare reports successful syndication of MicroSurgery Institute of Houston

Northstar Healthcare Inc. today announced the successful syndication of its newly formed operating partnership MicroSurgery Institute of Houston ("MSI") with an initial seven physician partners. Northstar will participate in the MSI partnership by leasing the surgery center assets and staff of The Palladium for Surgery - Houston, Ltd. partnership ("Palladium") to MSI for an ownership interest of 25%.

23 Dec 2010

Medical News

Santen files IND for Clinical Data's ATL313 for primary open angle glaucoma and ocular hypertension

Arsenic agent for leukemia beneficial in treating medulloblastoma, Ewing's Sarcoma

Procognia grants Euro-Diagnostica license to provide diagnostic services for gastric cancer

Promising initial data from STABLE clinical trial for endovascular treatment of Type B aortic dissection

Pelosi supports James Zadroga 9/11 Health and Compensation Act on the House floor

St. Luke’s second in nation to perform EVAR with Endurant AAA Stent Graft System

Scientist discovers molecular switch controlling synthesis of ribosomes

Key to long-term weight-loss success is finding unique individual level of carbohydrate tolerance

Later onset of puberty associated with malnutrition, earlier onset to childhood obesity

Discovery highlights potential to combat HIV/AIDS

Congress approves stopgap spending measure; Some funding for federal agencies, global health programs delayed

BioTime enters MTA with UC to make research-grade hES cell lines

EPA to clean up vector-breeding site to eliminate dengue epidemic

Immunization with VLP vaccine results in functional, protective immune responses against RSV

AADR testifies at FDA Advisory Panel meeting on dental amalgam

BSD in final process of establishing international distribution networks for new microwave ablation product line

Liberty Dialysis and Renal Advantage to form the third largest dialysis provider in the U.S.

Myrexis commences Azixa controlled two-arm Phase 2b clinical study in GBM

Researchers identify new regulator that play a critical role in B cell development

Northstar Healthcare reports successful syndication of MicroSurgery Institute of Houston

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News